Leaflet LUMOBRY 0.25mg / ml ophthalmic drops solution

Product code:
W70321001
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
brimonidine (glaucoma agent)
ATC
S01GA07 — Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants
Brimonidine is a medication used to treat open-angle glaucoma and ocular hypertension. It belongs to the class of alpha-2 adrenergic receptor agonists and works by reducing the production of aqueous humor and increasing its outflow, thereby lowering intraocular pressure.

It is available as eye drops and is typically administered two to three times a day, as directed by a doctor. Brimonidine is effective in preventing optic nerve damage caused by elevated intraocular pressure.

Side effects may include a burning or stinging sensation in the eyes, dry eyes, redness, headache, drowsiness, or dizziness. It is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) and should be used with caution in those with severe cardiovascular conditions.

General data about LUMOBRY 0.25mg / ml

Substance:
brimonidine
Date of latest medicines list:
01-07-2024
Product code:
W70321001
Concentration:
0.25mg / ml
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Original
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
BAUSCH+LOMB IRELAND LIMITED - IRLANDA
Holder:
BAUSCH+LOMB IRELAND LIMIT - IRLANDA
Number:
15476/2024/01
Shelf life:
2 years-after packaging for sale;after the first opening of the bottle-121 days

Pharmaceutical forms available for brimonidine

Concentrations available for brimonidine

  • 0.25mg/ml
  • 2mg/ml
  • 3mg/g

Combinations with other substances